Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Skye

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cell Host & Microbe|December 16, 2016
Microbial Modulation of a Uremic ToxinSarah M Skye, Stanley L Hazen
Journal of Lipid Research|December 11, 2019
Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseasesIbrahim Choucair, Ina Nemet, Lin Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2020
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney DiseaseNilaksh Gupta, Jennifer A Buffa, Adam B Roberts, et al.
The American Journal of Medicine|April 19, 2021
Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical TrialJennifer Wilcox, Sarah M Skye, Brett Graham, et al.
Circulation Research|October 26, 2018
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis PotentialSarah M Skye, Weifei Zhu, Kymberleigh A Romano, et al.
Mbio|November 10, 2023
Microbe-derived uremic solutes enhance thrombosis potential in the hostIna Nemet, Masanori Funabashi, Xinmin S Li, et al.
Cell|March 7, 2020
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic ReceptorsIna Nemet, Prasenjit Prasad Saha, Nilaksh Gupta, et al.
JCI Insight|March 23, 2018
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease riskXinmin S Li, Zeneng Wang, Tomas Cajka, et al.
Nature Medicine|August 8, 2018
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potentialAdam B Roberts, Xiaodong Gu, Jennifer A Buffa, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cell Host & Microbe|December 16, 2016
Microbial Modulation of a Uremic ToxinSarah M Skye, Stanley L Hazen
Journal of Lipid Research|December 11, 2019
Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseasesIbrahim Choucair, Ina Nemet, Lin Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2020
Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney DiseaseNilaksh Gupta, Jennifer A Buffa, Adam B Roberts, et al.
The American Journal of Medicine|April 19, 2021
Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical TrialJennifer Wilcox, Sarah M Skye, Brett Graham, et al.
Circulation Research|October 26, 2018
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis PotentialSarah M Skye, Weifei Zhu, Kymberleigh A Romano, et al.
Mbio|November 10, 2023
Microbe-derived uremic solutes enhance thrombosis potential in the hostIna Nemet, Masanori Funabashi, Xinmin S Li, et al.
Cell|March 7, 2020
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic ReceptorsIna Nemet, Prasenjit Prasad Saha, Nilaksh Gupta, et al.
JCI Insight|March 23, 2018
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease riskXinmin S Li, Zeneng Wang, Tomas Cajka, et al.
Nature Medicine|August 8, 2018
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potentialAdam B Roberts, Xiaodong Gu, Jennifer A Buffa, et al.
Pageof 1